Latest updates for Mrk
Fresh curated links around MRK are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- A Futuristic Synthesis Indeed
- Merck KGaA 2026 Q1 - Results - Earnings Call Presentation
- Merck KGaA: Diversified Innovation At An Attractive Valuation
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
seekingalpha.com
/1 month ago
Merck KGaA: Diversified Innovation At An Attractive Valuation
finance.yahoo.com
/2 weeks ago
Analyst Reinstates Merck (MRK) with ‘Neutral’ Rating, $125 Price Target
seekingalpha.com
/1 month ago
Merck KGaA (MKKGY) Presents at BNP Paribas Exane Healthcare Conference - Slideshow
seekingalpha.com
/1 month ago
Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside
roi-nj.com
/3 weeks ago
Merck completes purchase of Terns Pharmaceuticals Inc.
Merck & Co. said on May 5 that it has completed the acquisition of Terns Pharmaceuticals Inc., a drug maker from Foster City, Calif., for $6.7 billion in a deal that brings pro...
roi-nj.com
/1 month ago
Merck initiates Phase 2b/3 trial for treatment of age-related macular degeneration
Rahway-based Merck announced the initiation of a pivotal Phase 2b/3 trial evaluating MK-8748 (also known as Tiespectus, EYE201). It is a novel investigational bispecific antibody t...
pharmexec.com
/1 month ago
<![CDATA[Pharma M&A Roundup: IMG Pharma Acquires Matsumoto Pharmaceutical, Sun Pharma Acquires Organon ]]>
finance.yahoo.com
/1 month ago
TD Cowen Raises its Price Target on Marex Group plc (MRX) to $66 from $61
seekingalpha.com
/1 week ago
Marks and Spencer Group plc (MAKSY) Q4 2026 Earnings Call Transcript
seekingalpha.com
/1 week ago
Marks and Spencer Group plc 2026 Q4 - Results - Earnings Call Presentation
cafepharma.com
/1 week ago
Milestone
Milestone Anonymous (not verified) Mon, 05/18/2026 - 08:33 field_thread_url https://cafepharma.com/boards/threads/milestone.694258/ boar...
pharmexec.com
/1 month ago
<![CDATA[Eli Lilly Enters $7 Billion Agreement to Acquire Kelonia Therapeutics ]]>
cnbc.com
/1 month ago
Merck shares are forming a bullish chart pattern, and a breakout could be on the horizon
The pharmaceutical giant is a standout performer within the health-care sector, and the stock could be poised for a big jump.
biopharmadive.com
/1 week ago
Merck ADC, licensed from China, hits mark in first big global trial
The endometrial cancer trial is the first of 17 late-stage studies Merck is running for a therapy that’s important to its ambitions of hitting $70 billion in annual sales next deca...
seekingalpha.com
/1 month ago
Mallinckrodt plc 2025 Q4 - Results - Earnings Call Presentation
seekingalpha.com
/1 week ago
Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable
seekingalpha.com
/3 weeks ago
Mirum raises 2026 net product sales outlook to $660M-$680M as it targets year-end zilurgisertib launch
seekingalpha.com
/5 days ago
McCormick: Unilever Synergies Create A Great Long-Term Story
seekingalpha.com
/1 month ago
Mr Price Group Limited (MRPLY) Discusses NKD Acquisition Completion and Integration Plans - Slideshow
tradebrains.in
/1 month ago
Lords Mark Industries Secures Global HIV Kit License; Targets Exports to Africa & Europe
Synopsis: Lords Mark Industries Limited has attracted market interest after securing a manufacturing license for HIV diagnostic medical devices. This marks a key step in its expans...
seekingalpha.com
/1 month ago
Johnson & Johnson: Success In Multiple Myeloma Underpins $25B In Growth By 2030
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Mrk
seekingalpha.com
Recent coverage from public sources
Public source
cafepharma.com
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
search.cnbc.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source